| Not Yet Recruiting | A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant NCT07267208 | Jongman Kim | Phase 2 |
| Not Yet Recruiting | To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients NCT06589518 | Jongman Kim | Phase 2 |
| Recruiting | Impact of Hepatitis B Virus on Inflammatory Bowel Disease NCT06881238 | Tanta University | — |
| Not Yet Recruiting | Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes NCT06691412 | Assiut University | Phase 3 |
| Withdrawn | Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy NCT04046107 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Recruiting | HepB mAb19 in Individuals With Chronic Hepatitis B Infection NCT05856890 | Rockefeller University | Phase 1 |
| Not Yet Recruiting | A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma NCT05752890 | National Taiwan University Hospital | — |
| Unknown | Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B NCT04850950 | The First Affiliated Hospital of Zhengzhou University | Phase 4 |
| Recruiting | Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA. NCT04231565 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Withdrawn | Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demons NCT04385524 | University of Louisville | N/A |
| Completed | Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District NCT04072211 | Centre for Infectious Disease Research in Zambia | Phase 4 |
| Unknown | Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B NCT04065230 | Southeast University, China | — |
| Unknown | NK Cell Deregulation in HBV Patients NCT03761875 | University Hospital, Limoges | N/A |
| Completed | A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, NCT03570658 | Hoffmann-La Roche | Phase 1 |
| Completed | Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease. NCT03459521 | Corporacion Parc Tauli | N/A |
| Completed | Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient NCT03294798 | Tianjin SinoBiotech Ltd. | Phase 1 / Phase 2 |
| Completed | A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical S NCT03083821 | Bristol-Myers Squibb | Phase 1 |
| Completed | Effects of Antiviral Therapy on Patients With HBV-related HCC NCT05406089 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function a NCT02296853 | Gilead Sciences | Phase 1 |
| Completed | Hepatocellular Carcinoma in HIV-infected Patients NCT02785835 | Hospital Universitario de Valme | — |
| Completed | Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa NCT02060162 | University of Alabama at Birmingham | — |
| Completed | Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis NCT01204762 | Bristol-Myers Squibb | Phase 2 |
| Unknown | The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Pati NCT01083251 | Ziv Hospital | N/A |
| Unknown | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Relat NCT00960518 | Tongji University | Phase 2 |
| Completed | Mutations of the Pre-core Region of Hepatite B Virus (HBV) NCT03625258 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CH NCT00805675 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocyto NCT00678587 | GlaxoSmithKline | Phase 3 |
| Unknown | A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infe NCT00660361 | Bayside Health | — |
| Unknown | Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis NCT00663182 | Shanghai Changzheng Hospital | Phase 4 |
| Completed | Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication NCT00769730 | Kaohsiung Medical University Chung-Ho Memorial Hospital | — |
| Unknown | Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma NCT00768157 | Sun Yat-sen University | Phase 4 |
| Completed | A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection NCT00476411 | The HIV Netherlands Australia Thailand Research Collaboration | N/A |
| Completed | Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection NCT00476463 | The HIV Netherlands Australia Thailand Research Collaboration | Phase 2 |
| Completed | Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics NCT00739752 | Indiana University | N/A |
| Completed | Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in O NCT01438424 | Bristol-Myers Squibb | Phase 2 |
| Completed | Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma NCT00912847 | Chinese University of Hong Kong | — |
| Completed | Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting NCT00876148 | Azienda Ospedaliera San Giovanni Battista | — |